Cargando…

Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity

PURPOSE: Neoadjuvant radiochemotherapy (RCTH) is proven to be highly effective in the treatment of esophageal cancer (EC). We investigated oncological outcome and morbidity in patients treated with a modified CROSS protocol followed by esophagectomy at our institution. METHODS: Patients with EC rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paireder, Matthias, Jomrich, Gerd, Kristo, Ivan, Asari, Reza, Rieder, Erwin, Beer, Andrea, Ilhan-Mutlu, Aysegül, Preusser, Matthias, Schmid, Rainer, Schoppmann, Sebastian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449995/ https://www.ncbi.nlm.nih.gov/pubmed/32055873 http://dx.doi.org/10.1007/s00066-020-01594-z

Ejemplares similares

Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility
por: Paireder, Matthias, et al.
Publicado: (2020)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility—a safety and efficacy study
por: Paireder, Matthias, et al.
Publicado: (2019)

MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2018)

Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction
por: Feka, Joy, et al.
Publicado: (2023)

External validation of the NUn score for predicting anastomotic leakage after oesophageal resection
por: Paireder, Matthias, et al.
Publicado: (2017)

Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study
por: Paireder, Matthias, et al.
Publicado: (2018)

Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors
por: Kristo, Ivan, et al.
Publicado: (2018)

High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma
por: Jomrich, Gerd, et al.
Publicado: (2019)

Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Silent Gastroesophageal Reflux Disease in Patients with Morbid Obesity Prior to Primary Metabolic Surgery
por: Kristo, Ivan, et al.
Publicado: (2020)

Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
por: Gensthaler, Lisa, et al.
Publicado: (2023)

Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma
por: Kollmann, Dagmar, et al.
Publicado: (2017)

PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
por: Beer, Andrea, et al.
Publicado: (2020)

Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy
por: Jomrich, Gerd, et al.
Publicado: (2021)

Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer
por: Jomrich, G., et al.
Publicado: (2017)

Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis
por: Puhr, Hannah C., et al.
Publicado: (2021)

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma
por: Puhr, Hannah C., et al.
Publicado: (2023)

Additional fundophrenicopexia, after Nissen fundoplication, reduces postoperative dysphagia and re-operation rate in the long-term follow up
por: Nikolic, Milena, et al.
Publicado: (2021)

Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?
por: Puhr, Hannah Christina, et al.
Publicado: (2021)

Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)
por: Puhr, H.C., et al.
Publicado: (2022)

Dietary sugar and Barrett’s esophagus
por: Riegler, M., et al.
Publicado: (2017)

Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis
por: Puhr, H. C., et al.
Publicado: (2019)

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

NephroCheck data compared to serum creatinine in various clinical settings
por: Pajenda, Sahra, et al.
Publicado: (2015)

Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer
por: Puhr, Hannah Christina, et al.
Publicado: (2023)

Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times
por: Berghoff, Anna Sophie, et al.
Publicado: (2013)

Swallowing MRI—a reliable method for the evaluation of the postoperative gastroesophageal situs after Nissen fundoplication
por: Arnoldner, Michael A., et al.
Publicado: (2018)

Tailored modern GERD therapy – steps towards the development of an aid to guide personalized anti-reflux surgery
por: Nikolic, Milena, et al.
Publicado: (2019)

Targeted therapy in gastric cancer
por: Jomrich, G., et al.
Publicado: (2016)

Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy
por: Puhr, Hannah C., et al.
Publicado: (2022)

Update on the management of Barrett’s esophagus in Austria
por: Riegler, M., et al.
Publicado: (2017)

Radiochemotherapy
Publicado: (1998)

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
por: Negri, F V, et al.
Publicado: (2008)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

A pilot study of the endomicroscopic assessment of tumor extension in Barrett’s esophagus–associated neoplasia before endoscopic resection
por: Dolak, Werner, et al.
Publicado: (2015)

Preoperative Concurrent Radiochemotherapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer
por: Kang, Min Kyu, et al.
Publicado: (2006)

Prognostic Significance of Tumor Regression in Locally Advanced Rectal Cancer after Preoperative Radiochemotherapy
por: Omejc, Mirko, et al.
Publicado: (2017)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bshj75stnsp5c7ggg6edjmekas